Phase 1/2 Study of Rina-S in Patients With Locally Advanced and/or Metastatic Solid Tumors
This clinical trial is testing a new investigational drug called Rina-S, either alone or with other medicines, for people with advanced solid tumor cancers. The main goal is to check the safety and side effects of Rina-S to see how well it works for patients.
You may be able to join if you have certain types of advanced or spreading cancers, such as ovarian, lung, breast, or uterine cancer, and have already tried standard treatments. Your tumors also need to be measurable on standard scans.
Participants will receive the study medication, Rina-S, and possibly other approved cancer treatments while being closely monitored by the medical team for side effects. You will have regular check-ups and scans to see how your body is responding to the treatment.
This study is currently recruiting participants and is taking place at medical centers in Phoenix and Tucson, Arizona, as well as Los Angeles, California.
- 1Tests a new anti-cancer drug called Rina-S for advanced solid tumors
- 2Open to patients who have already tried standard treatments for specific cancers
- 3Currently recruiting at locations in Arizona and California
No related links yet
Seen this study covered in the news, or found a page that explains it well? Send it over and we'll review it.
Suggest a linkThis summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.